Short-term effects of intravitreal anti-vascular endothelial growth factor agents on body weight and multiple systems after treatment for retinopathy of prematurity.

Chen, Jing; Hao, Qingfei; Zhang, Jing; Du, Yanna; Chen, Haoming; Cheng, Xiuyong

Chen, Jing; Hao, Qingfei; Zhang, Jing; Du, Yanna; Chen, Haoming; Cheng, Xiuyong.

Afiliação

Chen J; Department of Neonatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Hao Q; Department of Neonatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhang J; Department of Neonatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Du Y; Department of Neonatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Chen H; Department of Neonatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Cheng X; Department of Neonatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Front Pediatr ; 10: 1077137, 2022.

Article em En | MEDLINE | ID: mdl-36760690

Palavras-chave

aflibercept; body weight gain; intravitreal anti-VEGF; multiple systems; ranibizumab; retinopathy of prematurity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pediatr Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google